BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 35331246)

  • 1. Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms.
    Kaushik N; Borkar SB; Nandanwar SK; Panda PK; Choi EH; Kaushik NK
    J Nanobiotechnology; 2022 Mar; 20(1):152. PubMed ID: 35331246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-restricted delivery through stimuli-responsive nanocarriers for lung cancer therapy.
    Dinakar YH; Karole A; Parvez S; Jain V; Mudavath SL
    Life Sci; 2022 Dec; 310():121133. PubMed ID: 36306866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Light-Responsive and Dual-Targeting Liposomes: From Mechanisms to Targeting Strategies.
    Agiba AM; Arreola-Ramírez JL; Carbajal V; Segura-Medina P
    Molecules; 2024 Jan; 29(3):. PubMed ID: 38338380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Endogenous and Exogenous Stimuli-Responsive Nanocarriers for Drug Delivery and Therapeutics.
    Hatakeyama H
    Chem Pharm Bull (Tokyo); 2017; 65(7):612-617. PubMed ID: 28674332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimuli-responsive Polymeric Nanosystems for Therapeutic Applications.
    Handa M; Singh A; Flora SJS; Shukla R
    Curr Pharm Des; 2022; 28(11):910-921. PubMed ID: 34879797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional and stimuli-responsive nanocarriers for targeted therapeutic delivery.
    Majumder J; Minko T
    Expert Opin Drug Deliv; 2021 Feb; 18(2):205-227. PubMed ID: 32969740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemo-drug Controlled-release Strategies of Nanocarrier in the Development of Cancer Therapeutics.
    Liu Y; Ou H; Pei X; Jiang B; Ma Y; Liu N; Wen C; Peng C; Hu X
    Curr Med Chem; 2021; 28(31):6307-6322. PubMed ID: 32503398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimuli-responsive image-guided nanocarriers as smart drug delivery platforms.
    Chen X; Lei S; Lin J; Huang P
    Expert Opin Drug Deliv; 2022 Nov; 19(11):1487-1504. PubMed ID: 36214740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents-An in-depth review of the last two decades.
    Devnarain N; Osman N; Fasiku VO; Makhathini S; Salih M; Ibrahim UH; Govender T
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jan; 13(1):e1664. PubMed ID: 32808486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox Nano-Architectures: Perspectives and Implications in Diagnosis and Treatment of Human Diseases.
    Sufi SA; Pajaniradje S; Mukherjee V; Rajagopalan R
    Antioxid Redox Signal; 2019 Feb; 30(5):762-785. PubMed ID: 29334759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimuli-responsive (nano)architectures for phytochemical delivery in cancer therapy.
    Zandieh MA; Farahani MH; Daryab M; Motahari A; Gholami S; Salmani F; Karimi F; Samaei SS; Rezaee A; Rahmanian P; Khorrami R; Salimimoghadam S; Nabavi N; Zou R; Sethi G; Rashidi M; Hushmandi K
    Biomed Pharmacother; 2023 Oct; 166():115283. PubMed ID: 37567073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors.
    Din FU; Aman W; Ullah I; Qureshi OS; Mustapha O; Shafique S; Zeb A
    Int J Nanomedicine; 2017; 12():7291-7309. PubMed ID: 29042776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade.
    Sohail M; Guo W; Li Z; Xu H; Zhao F; Chen D; Fu F
    Curr Med Chem; 2021; 28(19):3753-3772. PubMed ID: 33019919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies To Design and Synthesize Polymer-Based Stimuli-Responsive Drug-Delivery Nanosystems.
    Qin X; Li Y
    Chembiochem; 2020 May; 21(9):1236-1253. PubMed ID: 31889379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Properties of Tumor Microenvironments for Controlling Local, On-Demand Delivery from Biopolymer-Based Nanocarriers.
    Alshememry AK; El-Tokhy SS; Unsworth LD
    Curr Pharm Des; 2017; 23(35):5358-5391. PubMed ID: 28530543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart synthetic polymer nanocarriers for controlled and site-specific drug delivery.
    Balaure PC; Grumezescu AM
    Curr Top Med Chem; 2015; 15(15):1424-90. PubMed ID: 25877097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Smart Dual-Stimuli Responsive Nanoparticles for Controlled Anti-Tumor Drug Release and Cancer Therapy.
    Wu F; Qiu F; Wai-Keong SA; Diao Y
    Anticancer Agents Med Chem; 2021; 21(10):1202-1215. PubMed ID: 32972353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Application of Stimuli-responsive Nanocarriers for Targeted Drug Delivery.
    Zhou M; Wen K; Bi Y; Lu H; Chen J; Hu Y; Chai Z
    Curr Top Med Chem; 2017; 17(20):2319-2334. PubMed ID: 28240179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
    Du JZ; Li HJ; Wang J
    Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.